Open Source Health announces Sasha Ottey, Founder of PCOS Challenge to the Advisory Board

Investor News Press Releases

Toronto, Ontario, Canada – September 23, 2015: Open Source Health Inc. (CSE:OSH), (Frankfurt:0OS), a cloud based integrative and personalized healthcare platform that puts control into the hands of women to educate, advocate and collaborate on their own healthcare is pleased to announce that Sasha Ottey, Founder of PCOS Challenge has joined the advisory board of OSH.

“Sasha Ottey is the leading patient voice for Polycystic Ovary Syndrome (PCOS) and with over 30,000 women in her global network, she has her finger on the pulse of the PCOS Community,” says Sonya Satveit, “With our patient-centric focus on PCOS, Sasha’s tremendous credentials as a patient advocate and Founder of PCOS Challenge makes her a perfect addition to our board. I couldn’t be more thrilled to get to work with Sasha.”

“OSH is boldly on the cutting edge of discovering novel integrative and personalized treatments for women with PCOS,” states Sasha Ottey, “I am excited to be a part of creating real-world solutions for women who have this complex and misunderstood syndrome.”

The launch of the myAVA platform will focus on Polycystic Ovary Syndrome (PCOS), which is the leading endocrine disorder among reproductive women and the number one cause of infertility. This life-long syndrome affects 7 million women in America and puts women at high risk for diabetes and cardiovascular disease, yet receives less than 0.1% of NIH research funding. By approaching this complex syndrome at the molecular level, we gain the ability to understand and address the underlying issues at the individual patient level while achieving a new understanding of PCOS. As a member of OSH’s Advisory Board Ms. Ottey will provide unique insights on the patient perspective to help us provide a truly patient-centered approach to one of the most troubling and underserved women’s health issues, Polycystic Ovary Syndrome (PCOS).

The Company has issued 25,000 stock option in accordance with the Stock Option Plan.

About Sasha Ottey:

Sasha Ottey is Founder and Executive Director of PCOS Challenge, Inc. Sasha started the organization after she was diagnosed with PCOS and experienced great dissatisfaction with the availability of support resources for the condition. Since it’s founding in 2009, PCOS Challenge, Inc. has quickly grown to over 30,000 members worldwide, including it’s online and offline support groups.

PCOS Challenge is innovative in its multimedia approach to support. It produces the PCOS Challenge television show, a health series which follows ten women with Polycystic Ovary Syndrome as they have their lives transformed by naturopathic and allopathic medical experts and coaches. Its website, PCOSChallenge.com has been called the “Facebook for women with PCOS” by its members, and its popular PCOS Challenge radio show features internationally recognized PCOS experts, New York Times best-selling authors and real life stories from women with PCOS. The organization also provides offline support networks, webinars, and educational products.

Sasha is a Clinical and Research Microbiologist with a Bachelor’s degree in Clinical Laboratory Science from Howard University and a Master’s in Health Administration from the University of Phoenix.

About Open Source Health Inc.:

Open Source Health takes a truly patient-centered approach and is in the business of providing a real-time integrative healthcare solution for women in an open source architecture. Open Source Health Inc. is leading the digital transformation of integrative and preventative health by leveraging the latest trends in digital health, personalized health, social health and participatory medicine.

For more information, visit www.opensourcehealth.com

ON BEHALF OF THE BOARD OF DIRECTORS
Gary Bartholomew, Executive Chairman

Contact:

For further information, please contact Investor Relations at Open Source Health Inc.
Toll Free: 1.866.403.1933 in North America
International Calling: +01.647.872.9986
Website contact: www.opensourcehealth.com/contact-new


Forward Looking Statements

Certain information set forth in this news release may contain forward-looking statements that involve substantial known and unknown risks and uncertainties. These forward-looking statements are subject to numerous risks and uncertainties, certain of which are beyond the control of Open Source Health Inc. (“OSH”), including, but not limited to, the impact of general economic conditions, industry conditions and the uncertainty of obtaining additional financing. Readers are cautioned that the assumptions used in the preparation of such information, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements. Forward-looking statements contained in this press release are expressly qualified by this cautionary statement.

The forward-looking statements contained in this press release are made as of the date of this press release, and OSH does not undertake any obligation to update publicly or to revise any of the included forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable securities law.

Open Source Health announces Dr. Adam Perlman, leader in Integrative Medicine to the Advisory Board

Investor News Press Releases

Toronto, Ontario, Canada – September 16, 2015: Open Source Health Inc. (CSE:OSH), (Frankfurt:0OS), a cloud based integrative and personalized healthcare platform that puts control into the hands of women to educate, advocate and collaborate on their own healthcare is pleased to announce that Dr. Adam Perlman, Executive Director of Duke Integrative Medicine and Associate Professor of Duke University School of Medicine has joined the advisory board of OSH.

“Dr. Perlman is a renowned thought-leader and innovator in the field of integrative medicine. His achievements are a testament to the incredible leadership role he plays in the healthcare sector,” says Sonya Satveit, CEO of Open Source Health Inc. “It is exciting to have Dr. Perlman’s expert guidance as we provide women access to the latest advancements in integrative medicine.”

“There is no doubt that integrative medicine is the healthcare for the 21st century”, states Dr. Adam Perlman, “The convergence of personalized medicine and integrative healthcare is a revolutionary approach and I am excited to be working with OSH on this new frontier in medicine.”

As a member of the Advisory Board, Dr. Perlman will provide guidance and recommendations on how to address the opportunities and challenges of bringing integrative medicine and personalized medicine together to advance women’s health. Our first application is one of the most troubling women’s health issues, Polycystic Ovarian Syndrome (PCOS) which is the leading cause of infertility and affects 7 million women in America. Approaching this complex syndrome at the molecular level will help us achieve a new understanding of PCOS and has the potential to provide precision integrative treatment programs based on each woman individually.

OSH has granted Dr. Perlman 100,000 stock options for his participation on the Advisory Board.

About Dr. Adam Perlman:

Adam Perlman, MD, MPH, FACP, is an Associate Professor of Medicine and works within the Duke University Health System as Executive Director of Duke Integrative Medicine and in a leadership role as Associate Vice President for Health and Wellness. He has responsibility for Duke’s Health and Wellness portfolio, including Duke Integrative Medicine, the Duke Diet and Fitness Center as well as the Duke Health and Fitness Center. In his role, he is contributing to the work of healthcare transformation within and beyond the University System. Additionally, he is the Founder and Director of the Leadership Program in Integrative Healthcare at Duke University. Since assuming his position in 2011, Dr. Perlman has worked to transform the business model for many aspects of Health and Wellness, including such changes as adding insurance coverage as well as a concierge Integrative Primary Care practice at Duke Integrative Medicine.

Dr. Perlman is past Chair for the Consortium of Academic Health Centers for Integrative Medicine, comprised of over 60 leading academic medical centers around the country. Prior to his work with Duke, Dr. Perlman was Executive Director for the Institute for Complementary and Alternative Medicine (ICAM) at the University of Medicine and Dentistry of New Jersey (UMDNJ), where he was Associate Professor of Medicine. He held the UMDNJ Hunterdon Endowed Professorship in Complementary and Alternative Medicine and was Chair for the Department of Primary Care within the School of Heath Related Professions, overseeing the Physician Assistant and Respiratory Care Programs.

Dr. Perlman served as Director of Integrative Medicine for the Saint Barnabas Health Care System and was founding Medical Director for the Carol and Morton Siegler Center for Integrative Medicine, in Livingston, New Jersey. He had primary responsibility for developing and overseeing the Complementary & Alternative Medicine Program, including the Integrative Medicine Center and the Center for Health and Wellness, for the largest healthcare system in New Jersey.

Dr. Perlman received his BA from Tufts University and his MD from Boston University School of Medicine, completing residencies in Internal Medicine and Preventive Medicine as well as a General Internal Medicine Research Fellowship at Boston Medical Center. He earned an MPH from the Boston University School of Public Health.

Dr. Perlman lectures widely and is a frequently featured media expert. His scholarly activities include numerous grants and publications. He was guest editor for the Complementary and Alternative Medicine volume of Medical Clinics of North America, and is associate editor for the Complementary and Alternative Medicine section of the Physician Information and Education Resource (PIER), developed by the American College of Physicians and American Society for Internal Medicine. His diverse research interests have included a clinical trial evaluating the effect of multivitamin supplementation on school performance in underserved children, a trial assessing the efficacy of massage for osteoarthritis of the knee and a survey exploring the use of CAM in patients with cancer. Most recently, he was the recipient of an R01 Research Grant, funded by the NIH’s National Center for Complementary and Alternative Medicine, to continue his research on massage therapy for osteoarthritis of the knee. Dr. Perlman’s research has been published in the Archives of Internal Medicine and featured in the New York Times.

About Open Source Health Inc.:

Open Source Health takes a truly patient-centered approach and is in the business of providing a real-time integrative healthcare solution for women in an open source architecture. Open Source Health Inc. is leading the digital transformation of integrative and preventative health by leveraging the latest trends in digital health, personalized health, social health and participatory medicine.

For more information, visit www.opensourcehealth.com

Contact:

For further information, please contact Investor Relations at Open Source Health Inc.
Toll Free: 1.866.403.1933 in North America
International Calling: +01.647.872.9986
Website contact: opensourcehealth.com


Forward Looking Statements

Certain information set forth in this news release may contain forward-looking statements that involve substantial known and unknown risks and uncertainties. These forward-looking statements are subject to numerous risks and uncertainties, certain of which are beyond the control of Open Source Health Inc. (“OSH”), including, but not limited to, the impact of general economic conditions, industry conditions and the uncertainty of obtaining additional financing. Readers are cautioned that the assumptions used in the preparation of such information, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements. Forward-looking statements contained in this press release are expressly qualified by this cautionary statement.

The forward-looking statements contained in this press release are made as of the date of this press release, and OSH does not undertake any obligation to update publicly or to revise any of the included forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable securities law.